%0 Journal Article
%A Taugner, Julian
%A Käsmann, Lukas
%A Eze, Chukwuka
%A Rühle, Alexander
%A Tufman, Amanda
%A Reinmuth, Niels
%A Duell, Thomas
%A Belka, Claus
%A Manapov, Farkhad
%T Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients.
%J Investigational new drugs
%V 39
%N 4
%@ 1573-0646
%C Dordrecht [u.a.]
%I Springer Science + Business Media B.V
%M DKFZ-2021-00600
%P 1189-1196
%D 2021
%Z 2021 Aug;39(4):1189-1196
%X The aim of this prospective study is to evaluate the clinical use and real-world efficacy of durvalumab maintenance treatment after chemoradiotherapy (CRT) in unresectable stage, locally advanced non-small cell lung cancer (NSCLC). All consecutive patients with unresectable, locally advanced NSCLC and PD-L1 expression (≥1
%K Checkpoint inhibition (Other)
%K Chemoradiotherapy (Other)
%K Non-small cell lung cancer (Other)
%K PD-L1 inhibitor (Other)
%K Treatment pattern (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:33704621
%R 10.1007/s10637-021-01091-9
%U https://inrepo02.dkfz.de/record/167866